Marshall Wace portfolio

Marshall Wace has 10 portfolio companies on record at Recent Funding, with 3 investments in the last 12 months.

Type: Investor.

Portfolio on Recent Funding: 10.

Deals, last 12 months: 3.

Rounds led: 1 of 12.

Capital in their rounds: $1.25B.

Latest deal: Draig Therapeutics · Jul 14, 2026.

About this page

It led 1 of the 12 rounds it joined. Its most recent investment on record is Draig Therapeutics's $65M Series B+ round in July 2026, alongside Jefferson Life Sciences, Janus Henderson Investors, Deep Track Capital and 1 other. By category, its portfolio leans toward Health and bio (8) and Stablecoins (1). It has co-invested with Janus Henderson Investors, Logos Capital and Deep Track Capital, most often Janus Henderson Investors (4 rounds).

What Marshall Wace invests in

Health and bio · 8 · 80%
Stablecoins · 1 · 10%
RWA and tokenization · 1 · 10%
L1s, L2s and rollups · 1 · 10%
ZK and privacy · 1 · 10%
Crypto security · 1 · 10%
Fintech · 1 · 10%
Developer tools and cloud · 1 · 10%

Marshall Wace recent investments

Company	Round	Date	Alongside
DDraig Therapeutics	Series B+ · $65M	Jul 14, 2026	Jefferson Life Sciences, Janus Henderson Investors, Deep Track Capital (lead) +1
AArc blockchain	round · $222M	May 1, 2026	Apollo Global Management, Haun Ventures, ARK Invest +8
TThird Arc Bio	Series A · $52M	Feb 4, 2026	Aberdeen, Galapagos, Goldman Sachs Alternatives +6
335Pharma	Series B+	Nov 26, 2024	Janus Henderson Investors, Deep Track Capital, Surveyor Capital +6
IInquis Medical	Series B+ · $40M · lead	Nov 4, 2024	Shangbay Capital, En Pointe, Yu Galaxy +1
TThird Arc Bio	Series A · $165M	Jul 22, 2024	Vida Ventures (lead), Janus Henderson Investors, Goldman Sachs Alternatives +6
AAreteia Therapeutics	Series A · $75M	Feb 13, 2024	Access Biotechnology, Viking Global Investors, Maverick Capital +6
TTRM Labs	Series B+ · $70M	Nov 9, 2022	Green D Ventures, Goldman Sachs, DRW Venture Capital +6

How Marshall Wace invests

Stage	Deals	Capital in rounds
Series B+	8 67%	$733M
Series A	3 25%	$292M
round	1 8%	$222M

Year	Deals	Capital in rounds
2021	4 33%	$558M
2022	1 8%	$70M
2024	4 33%	$280M
2026	3 25%	$339M

Marshall Wace portfolio companies

DDraig Therapeutics$65MSeries B+ · Jul 2026
AArc blockchain$222Mround · May 2026
TThird Arc Bio$52MSeries A · Feb 2026
335PharmaSeries B+ · Nov 2024
IInquis Medical$40MSeries B+ · Nov 2024
AAreteia Therapeutics$75MSeries A · Feb 2024
TTRM Labs$70MSeries B+ · Nov 2022
TTipalti$270MSeries B+ · Dec 2021
AAsher Bio$108MSeries B+ · Sep 2021
FForge Biologics$120MSeries B+ · Apr 2021

Company	Round with Marshall Wace	Total raised	Latest raise
DDraig Therapeutics Health and bio	Jul 14, 2026 Series B+ · $65M	$205M	Jul 14, 2026 Series B+
AArc blockchain Stablecoins	May 1, 2026 round · $222M	$222M	May 1, 2026 round
TThird Arc Bio Health and bio	Feb 4, 2026 Series A · $52M	$217M	Feb 4, 2026 Series A
335Pharma Health and bio	Nov 26, 2024 Series B+	undisclosed	Nov 26, 2024 Series B+
IInquis Medical Health and bio	Nov 4, 2024 Series B+ · $40M · lead	$115M	Jan 13, 2026 Series B+
AAreteia Therapeutics Health and bio	Feb 13, 2024 Series A · $75M	$75M	Feb 13, 2024 Series A
TTRM Labs ZK and privacy	Nov 9, 2022 Series B+ · $70M	$219.9M	Sep 10, 2026 Series B+
TTipalti Fintech	Dec 1, 2021 Series B+ · $270M	$739M	Sep 24, 2025 round
AAsher Bio Health and bio	Sep 1, 2021 Series B+ · $108M	$218M	Apr 16, 2024 Series B+
FForge Biologics Health and bio	Apr 29, 2021 Series B+ · $120M	$250M	Sep 12, 2022 Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 12 rounds on Recent Funding that name Marshall Wace. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Marshall Wace, which is a subset of its real portfolio. API: /api/v1/investors/marshall-wace (get a free API key). More: the most active VC firms and new venture capital funds.